Cambridge Acquisition Corp. 8-K

What Happened

• Cambridge Acquisition Corp. announced it consummated its initial public offering (IPO) on February 9, 2026. The offering consisted of 23,000,000 units (including 3,000,000 units from the underwriters’ over‑allotment) at $10.00 per unit, generating $230,000,000 in gross IPO proceeds.
• Simultaneously the company completed a private placement of 495,500 units to Cambridge Sponsor LLC at $10.00 per unit, raising $4,955,000. Each unit (both public and private) consists of one Class A ordinary share and one‑third of a redeemable warrant; each whole warrant is exercisable for one Class A share at $11.50 (subject to adjustment).
• A total of $230,000,000 was deposited in a U.S.‑based trust account maintained by Continental Stock Transfer & Trust Company. An audited balance sheet as of February 9, 2026 reflecting receipt of these proceeds is included as Exhibit 99.1 to the Form 8‑K.

Key Details

• 23,000,000 Units sold in the IPO, including 3,000,000 via over‑allotment.
• IPO price: $10.00 per Unit; gross IPO proceeds: $230,000,000.
• Private placement: 495,500 units to Cambridge Sponsor LLC for $4,955,000.
• Warrant terms: each whole warrant exercisable at $11.50 per share; trust account held by Continental Stock Transfer & Trust Company.

Why It Matters

• The $230M held in trust is the capital base the SPAC will use for pursuing merger targets and to cover potential redemptions; it is a key metric for investors assessing the SPAC’s ability to complete a business combination.
• The sponsor’s private purchase and the inclusion of warrants affect future share count and potential dilution; investors should note warrant strike price and the number of warrants outstanding when evaluating post‑combination economics.
• The filing includes an audited balance sheet reflecting these transactions, providing transparency about the company’s initial cash and capital structure.